
When the transition begins
The Office on Women's Health describes perimenopause as the years before menopause when hormone levels change and periods may become irregular. The Office on Women's Health defines menopause as 12 months in a row without a period or spotting. That timing means the last period can only be identified as the final one in hindsight. The Office on Women's Health places the usual menopause transition between ages 45 and 55 and gives 52 as the average age of menopause in the United States, in its overview of the transition.
During perimenopause, the ovaries may release an egg in some cycles and skip ovulation in others, according to the American College of Obstetricians and Gynecologists. Periods can come closer together or farther apart. The days of bleeding and the amount can change too. The Office on Women's Health notes that pregnancy is still possible with skipped periods during this stage. The page on hormones across life explains the signals between the ovaries and the brain.
The National Institute on Aging explains that a clinician may consider age, symptoms and family history when deciding whether the transition is a likely explanation. In some cases, such as periods stopping at an early age, the clinician may suggest a blood test for hormone levels. The same institute describes a different course when both ovaries are removed surgically. In that situation, a person who is without hormone therapy may notice that periods stop and menopause symptoms begin immediately.
What midlife symptoms can feel like
A hot flash is a sudden sensation of heat, often across the face and upper body, according to the National Institute on Aging. Skin may flush, and sweating can be followed by chills. Night sweats are hot flashes that happen at night. The institute distinguishes trouble falling asleep from waking during the night or waking early. A night sweat or the need to urinate can interrupt sleep, and someone who wakes may find it hard to fall back asleep.
The National Institute on Aging also describes vaginal dryness that can make sex uncomfortable, and bladder changes such as a sudden need to urinate or leakage with a sneeze or laugh. Pelvic floor and bladder health explains how clinicians describe different kinds of leakage. The same institute includes mood changes, aching or stiff joints, and trouble concentrating in its account of midlife symptoms. It notes that researchers are still examining how some changes relate to hormones and to aging.
The National Institute on Aging describes a wide range of experiences. Some women have few or mild symptoms, while symptoms for others can be more severe and last for years. The institute lists lifestyle changes, such as dressing in layers for hot flashes, among the approaches some women use. It also discusses nonhormonal medicines as a category. The choice of whether to pursue treatment is personal, and the institute describes clinicians considering symptoms, preferences and medical and family history.
What hormone therapy refers to
MedlinePlus describes menopause hormone therapy as estrogen alone or estrogen with progesterone or a similar hormone called progestin. It is a treatment a clinician prescribes and supervises. MedlinePlus notes that a clinician may recommend estrogen alone after a hysterectomy, which is surgery to remove the uterus. For someone with a uterus, ACOG's patient FAQ explains that progestin can reduce the risk of cancer of the uterine lining associated with estrogen alone.
Whole-body treatment, called systemic therapy, releases estrogen into the bloodstream, according to ACOG's explanation of hormone therapy. The FAQ describes pills, patches, gels and sprays as examples. It describes local estrogen as a form that acts directly in vaginal tissue. The group describes whole-body estrogen as a treatment for hot flashes and night sweats and both whole-body and local estrogen as options for vaginal dryness.
MedlinePlus lists blood clots, heart attack, stroke, breast cancer and gallbladder disease among concerns that can enter a clinician's assessment for some women. MedlinePlus says the level of risk depends on the type of hormone therapy, the length of use, and a person's medical history and lifestyle, in its discussion of possible harms. The Office on Women's Health distinguishes relief of menopause symptoms from using hormone therapy solely to prevent heart disease, which it advises against. It also lists reasons therapy is usually avoided, including unexplained vaginal bleeding, liver disease, hormone receptor-positive breast cancer, or a current or recent clot, stroke or heart attack.
Bone strength in later years
The National Institute of Arthritis and Musculoskeletal and Skin Diseases explains that osteoporosis makes bones weaker as bone mass or structure changes. It lists lower estrogen after menopause among factors associated with osteoporosis. The condition may have no symptoms until a bone breaks. The institute identifies the hip, spine and wrist as frequent sites of fractures in people with osteoporosis.
The U.S. Preventive Services Task Force describes bone density screening using dual-energy X-ray absorptiometry, an X-ray test abbreviated DXA. The task force recommends screening women aged 65 years or older and younger postmenopausal women who have increased fracture risk based on a clinical assessment, in its osteoporosis screening recommendation. The U.S. Preventive Services Task Force says its recommendation applies to adults aged 40 or older who have no known osteoporosis or history of fragility fractures. The task force excludes people with osteoporosis caused by another medical condition or by long-term use of a medicine associated with bone loss. The routine screening page places bone density screening alongside other kinds of preventive care.
Bleeding after menopause
ACOG's patient FAQ on bleeding describes lighter or heavier periods and missed periods as changes that can occur in perimenopause. The FAQ identifies bleeding or spotting between periods or after sex, heavy bleeding, bleeding that is heavier or lasts longer than usual, and bleeding after menopause as reasons to speak with an obstetrician-gynecologist. The Office on Women's Health says vaginal bleeding after menopause calls for seeing a health care provider right away.
Bleeding alone does not identify the cause. ACOG lists possible causes that include polyps, which are noncancerous growths, and a uterine lining that has become too thin. A lining that has grown too thick or cancer of the uterine lining may also cause bleeding. The same FAQ describes evaluation beginning with health history and sometimes a physical exam. Possible tests include an ultrasound, which makes pictures using sound waves, or a biopsy, which supplies a small sample of the uterine lining for examination under a microscope.
Sources
- Menopause basics | Office on Women's Health
- Perimenopausal Bleeding and Bleeding After Menopause | ACOG
- What Is Menopause? | National Institute on Aging
- Hormone Therapy for Menopause | MedlinePlus
- Hormone Therapy for Menopause | ACOG
- Hormone therapy safety | Office on Women's Health
- Osteoporosis Causes, Risk Factors, & Symptoms | NIAMS
- Recommendation: Osteoporosis to Prevent Fractures: Screening | United States Preventive Services Taskforce